The Trans-Pacific Partnership is setting a precedent that effectively can't be rolled back in the future, according to Congress leaders who hosted a press conference Friday morning.
Injectable and infusion drug company Hospira announced Thursday that the Food and Drug Administration had approved its bivalirudin injection, a generic of the Medicine Company’s Angiomax.
As many as 12% of pet owners have bought health insurance for their animals. And among millennials, that number jumps to 19%.
Ralph Neas, president and CEO of the Generic Pharmaceutical Association, issued a statement last month criticizing the FDA at the organization’s public meeting on the Generic Drug User Free Act.
Increasing access to birth control through the pharmacy may pose a challenge - will pharmacists who counsel patients on family planning be reimbursed for their efforts?
The new guidelines have been expected to increase the number of statin-eligible adults by almost 13 million.
A collection of eight consumer groups have written to Federal Trade Commission chair Edith Ramirez in opposition of the ongoing potential merger between pharmaceutical companies Teva and Mylan.
Almost half of all people in an employer wellness program and with a chronic condition learned of their health status through that wellness program.
As many as 84% of Americans want the full array of cough, cold and allergy remedies in the drug store aisles even if they aren't sick at the time.
Both Mylan and Dr. Reddy’s Laboratories have announced the launch of their generic version of dementia drug Namenda.